CN / EN
联系我们
QYAOBIO & Products and Services

Peptide Name

CAT#

Peptide Sequence

Antagonist G

1966-2-1

Arg-DTrp-NMe-Phe-DTrp-Leu-Met-NH2

Scyliorhinin I, amide, dogfish

1966-2-2

Ala-Lys-Phe-Asp-Lys-Phe-Tyr-Gly-Leu-Met-NH2

Scyliorhinin II, amide, dogfish

1966-2-3

Ser-Pro-Ser-Asn-Ser-Lys-Cys-Pro-Asp-Gly-Pro-Asp-Cys-Phe-Val-Gly-Leu-Met-NH2

Spantide II

1966-2-4

DLys(Nicotinoyl)-Pro-(3-Pyridyl)Ala-Pro-(3,4-dichloro)DPhe-Asn-DTrp-Phe-DTrp-Leu-Nle-NH2

Substance P

1966-2-5

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

Substance P (1-4)

1966-2-6

Arg-Pro-Lys-Pro

Substance P (1-7)

1966-2-7

Arg-Pro-Lys-Pro-Gln-Gln-Phe

Substance P (1-9)

1966-2-8

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly

Substance P (2-11)/Deca-Substance P

1966-2-9

Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

Substance P (3-11)/Nona-Substance P

1966-2-10

Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

Substance P (4-11)/Octa-Substance P

1966-2-11

Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

Substance P (5-11)/Hepta-Substance P

1966-2-12

Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

Substance P (6-11)/Hexa-Substance P

1966-2-13

Gln-Phe-Phe-Gly-Leu-Met-NH2

Substance P (7-11)

1966-2-14

Phe-Phe-Gly-Leu-Met-NH2

Substance P (9-11)

1966-2-15

Gly-Leu-Met-NH2

Substance P Methyl ester

1966-2-16

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-OMe

Substance P reversed sequence

1966-2-17

Met-Leu-Gly-Phe-Phe-Gln-Gln-Pro-Lys-Pro-Arg-NH2

Substance P, Free Acid

1966-2-18

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met

Substance P-Gly-Lys-Arg

1966-2-19

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-Gly-Lys-Arg

Substance P-Gly-Lys-Arg

1966-2-19

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-Gly-Lys-Arg

[Arg3] Substance P

1966-2-20

Arg-Pro-Arg-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

[Asp5,6,Me-Phe8] Substance P

1966-2-21

Asp-Asp-Phe-Me-Phe-Gly-Leu-Met-NH2

[DAla4] Substance P (4-11)

1966-2-22

DAla-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

[DArg1,DPhe5,DTrp7,9,Leu11] Substance P

1966-2-23

DArg-Pro-Lys-Pro-DPhe-Gln-DTrp-Phe-DTrp-Leu-Leu-NH2

[DArg1,DPro2,DPhe7,DHis9] Substance P

1966-2-24

DArg-DPro-Lys-Pro-Gln-Gln-DPhe-Phe-DHis-Leu-Met-NH2

[DArg1,DPro2,DTrp7,9,Leu11] Substance P

1966-2-25

DArg-DPro-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Leu-NH2

[DArg1,DTrp7,9,Leu11] Substance P

1966-2-26

DArg-Pro-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Leu-NH2

[Dehydro-Pro4] Substance P (4-11)

1966-2-27

Dehydro-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

[DPro2,DPhe7,DTrp9] Substance P

1966-2-28

Arg-DPro-Lys-Pro-Gln-Gln-DPhe-Phe-DTrp-Leu-Met-NH2

[DPro2,DTrp7,9] Substance P

1966-3-1

Arg-DPro-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Met-NH2

[DPro4,DTrp7,9,10] Substance P (4-11)

1966-3-2

DPro-Gln-Gln-DTrp-Phe-DTrp-DTrp-Met-NH2

[DPro4,DTrp7,9,Nle11] Substance P (4-11)

1966-3-3

DPro-Gln-Gln-DTrp-Phe-DTrp-Leu-Nle-NH2

[DPro4,DTrp7,9] Substance P (4-11)

1966-3-4

DPro-Gln-Gln-DTrp-Phe-DTrp-Leu-Met-NH2

[DTrp2,7,9] Substance P

1966-3-5

Arg-DTrp-Lys-Pro-Gln-Gln-DTrp-Phe-DTrp-Leu-Met-NH2

[Glp5,(Me)Phe8,Sar9] Substance P (5-11)

1966-3-6

Glp-Gln-Phe-(NMe)Phe-Sar-Leu-Met-NH2

[Glp5,Sar9] Substance P (5-11)

1966-3-7

Glp-Gln-Phe-Phe-Sar-Leu-Met-NH2

[Glp5] Substance P (5-11)

1966-3-8

Glp-Gln-Phe-Phe-Gly-Leu-Met-NH2

[Glp6,Pro9] Substance P (6-11)/Septide

1966-3-9

Glp-Phe-Phe-Pro-Leu-Met-NH2

[Glp6,Pro9] Substance P (6-11)/Septide

1966-3-9

Glp-Phe-Phe-Pro-Leu-Met-NH2

[Glp6] Substance P (6-11)

1966-3-10

Glp-Phe-Phe-Gly-Leu-Met-NH2

[Gly11] Substance P

1966-3-11

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Gly-NH2

[His11]Substance P

1966-3-12

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-His-NH2

[MePhe8,Sar9] Substance P

1966-3-13

Arg-Pro-Lys-Pro-Gln-Gln-Phe-(NMe)Phe-Sar-Leu-Met-NH2

[Nle11] Substance P

1966-3-14

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Nle-NH2

[Pro9] Substance P

1966-3-15

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Pro-Leu-Met-NH2

[Sar4] Substance P (4-11)

1966-3-16

Sar-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

[Sar9, Met(O2)11

1966-3-17

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met[O2]-NH2

[Sar9] Substance P

1966-3-18

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met-NH2

[Succinyl-Asp6,Me-Phe8] Substance P

1966-3-19

Succinyl-Asp-Phe-Me-Phe-Gly-Leu-Met-NH2

[Tyr8,Nle11] Substance P

1966-3-20

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Nle-NH2

[Tyr8] Substance P

1966-3-21

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Met-NH2

置顶

严正声明

近日,我司接到客户举报,有境外不法欺诈网站蓄意假冒我司官方网站,非法开展产品销售活动,混淆公众视听,严重误导客户,已对我司品牌声誉及广大客户合法权益造成恶劣侵害。为正本清源、捍卫合法权益,我司特此发布严正声明如下:

一、我司官方网站为:www.chinapeptides.com、www.qyaobio.com。除此以外,其余带 QYAOBIO/ChinaPeptides 的商城、零售网站全属仿冒侵权。我司无线上自助商城,不支持加密货币支付,绝不零售减重多肽针剂,任何线上直营零售宣传均为虚假, 与我司无任何关联,不具备任何合法性,纯属欺诈。

二、我司所有产品均采用直销模式进行销售,未授权任何非官方第三方平台、网站及个人代理销售我司产品。同时,我司全体销售人员(含全球各海外办事处工作人员)的工作邮箱,均以 chinapeptides.com、qyaobio.com 为域名结尾。凡非以上述域名结尾的邮箱,均不属于我司工作人员邮箱,切勿轻信相关沟通与交易邀约。

三、通过假冒网站所购产品,其来源、品质、合规性均不受我司任何认可与保障,存在重大质量风险。我司不对假冒产品承担任何质量责任、技术支持及售后服务。因购买、使用假冒产品所产生的一切损失、风险及法律责任,均由购买者自行承担,与我司无关。

四、产品使用范围:所有产品仅限科研实验,不可用于人 / 兽临床;严禁销售 Retatrutide、GHK-CU、BPC-157、CJC-1295 等品类,无相关货品。

五、对上述公然假冒我司名义从事非法经营的侵权行为,我司将固定完整证据,向公安机关报案并采取一切法律手段,坚决追究侵权主体全部法律责任,绝不姑息、绝不纵容。

我司郑重提醒广大客户,务必通过官方网站及认证渠道进行交易,严格核验网站域名与邮箱后缀,提高警惕,严防受骗,切实维护自身合法权益。

欢迎社会各界与客户对假冒网站及侵权行为进行监督举报,共同维护市场秩序与公平环境。

特此声明!

强耀生物